Clarivate PLC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
CLVT
Clarivate PLCForm 4: Clarivate Director Buys Shares
Kenneth L. Cornick, a Director of Clarivate Plc, purchased 900,000 shares of common stock on August 6, 2026.
NYSE
CLVT
Clarivate PLCForm 4: Clarivate Director Sells Shares
Andrew Miles Snyder, a Director of Clarivate Plc, sold 2,489,618 shares of common stock on August 3, 2026 for $1.94 per share.
NYSE
CLVT
Clarivate PLCClarivate PLC Director Kenneth L. Cornick reported transactions involving ordinary shares, including an award and tax withholdings.
NYSE
CLVT
Clarivate PLCAndrew Snyder, a Director at Clarivate PLC, received a quarterly award of ordinary shares valued at $51,250, elected in lieu of a cash retainer.
NYSE
CLVT
Clarivate PLCClarivate PLC President of IP, Simon Webster, acquired 396,825 ordinary shares as part of an equity compensation arrangement.
NYSE
CLVT
Clarivate PLCDirector Wendell Pritchett acquired 62,264 restricted share units and disposed of 3,367 shares for tax withholding purposes.
NYSE
CLVT
Clarivate PLCClarivate Plc director Jane Okun Bomba received an annual equity grant and settled tax obligations through share withholding.
NYSE
CLVT
Clarivate PLCDirector Saurabh Saha reported the withholding of shares for taxes and the receipt of an annual restricted share unit award.
NYSE
CLVT
Clarivate PLCDirector Kenneth Cornick acquired 62,264 restricted share units and disposed of 5,990 shares for tax withholding purposes.
NYSE
CLVT
Clarivate PLCDirector Andrew Snyder received an annual equity grant and withheld shares for taxes, resulting in a net increase in direct holdings.
NYSE
CLVT
Clarivate PLCDirector Suzanne Heywood reported a net increase in Clarivate Plc share ownership following an annual restricted share unit grant.
NYSE
CLVT
Clarivate PLCClarivate PLC President of Life Sciences & Healthcare, Henry Levy, reported the withholding of 19,893 shares to cover tax obligations.
NYSE
CLVT
Clarivate PLCClarivate Plc director Kenneth L. Cornick reported transactions involving ordinary shares, including a quarterly award and tax withholdings.
NYSE
CLVT
Clarivate PLCClarivate PLC reports a Form 4 filing detailing stock transactions by Director Jane L. Bomba, including share awards and tax withholdings.
NYSE
CLVT
Clarivate PLCAndrew Snyder, a Director at Clarivate PLC, acquired 20,256 ordinary shares through a quarterly award in lieu of cash compensation.
NYSE
CLVT
Clarivate PLCClarivate PLC's Senior VP of Finance and CAO, Michael M. Easton, reported a series of transactions including a charitable gift, acquisition of shares, and tax-related disposition.
NYSE
CLVT
Clarivate PLCClarivate PLC's EVP and Chief Information Officer, William E. Graff, reported the acquisition of 254,716 ordinary shares and the disposition of 23,838 shares for tax withholding related to restricted share unit vesting.
NYSE
CLVT
Clarivate PLCClarivate PLC CEO Matitiahu S. Shem Tov reported the acquisition of ordinary shares and a subsequent disposition for tax withholding.
NYSE
CLVT
Clarivate PLCClarivate PLC's President of A&G, Bar Veinstein, acquired 377,358 ordinary shares on March 15, 2026, increasing his beneficial ownership to 1,263,016 shares.
NYSE
CLVT
Clarivate PLCClarivate PLC's CFO, Jonathan Mark Collins, reported a net increase in his beneficial ownership of ordinary shares following an acquisition, tax-related disposal, and a divorce settlement transfer.
NYSE
CLVT
Clarivate PLCClarivate PLC's President of IP, Maroun S. Mourad, reported a future acquisition of 377,358 ordinary shares and a disposition of 105,000 shares by a spouse, effective March 15, 2026.
NYSE
CLVT
Clarivate PLCClarivate PLC's President of LS&H, Henry Levy, acquired 377,358 ordinary shares and had 35,402 shares withheld for taxes, increasing his direct beneficial ownership.
NYSE
CLVT
Clarivate PLCClarivate PLC's President of LS&H, Henry Levy, disposed of 37,342 ordinary shares at $2.3 each to cover tax liabilities from restricted share unit vesting.
NYSE
CLVT
Clarivate PLCClarivate PLC's Senior VP of Finance and CAO, Michael M. Easton, reported the acquisition of 4,266 ordinary shares and the disposal of 27,840 shares for tax withholding, with the filing noted as late due to administrative oversight.
NYSE
CLVT
Clarivate PLCClarivate PLC's CFO, Jonathan Mark Collins, reported the acquisition of shares from vested performance units and a subsequent disposition for tax purposes.
NYSE
CLVT
Clarivate PLCClarivate PLC's President of LS&H, Henry Levy, reported the acquisition of shares from vested performance units and the disposition of shares for tax obligations.
NYSE
CLVT
Clarivate PLCClarivate PLC Director Andrew Snyder received 15,344 ordinary shares as quarterly compensation, increasing his direct beneficial ownership.
NYSE
CLVT
Clarivate PLCClarivate Plc director Kenneth L. Cornick acquired 6,362 ordinary shares as part of his director compensation, while 2,399 shares were withheld for tax purposes.
NYSE
CLVT
Clarivate PLCClarivate PLC Director Jane L. Okun Bomba acquired 8,607 ordinary shares as compensation, with 243 shares withheld for taxes.
NYSE
CLVT
Clarivate PLCClarivate PLC's President of A&G, Bar Veinstein, sold 309,902 ordinary shares for a weighted average price of $3.74 per share, executed under a pre-arranged 10b5-1 trading plan.